|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine
Hyunwoo Lee, Yoon Ah Cho, Deok Geun Kim, Eun Yoon Cho
Cancer Res Treat.
2024;56(1):149-161. Published online August 11, 2023 DOI:
https://doi.org/10.4143/crt.2023.800
Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in
BRCA
Mutation Carriers: A Nationwide Study in South Korea
Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho
Cancer Res Treat.
2024;56(1):143-148. Published online August 16, 2023 DOI:
https://doi.org/10.4143/crt.2023.653
Gynecologic cancer
Effect of
BRCA
1/2
Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.
2023;55(1):245-257. Published online July 19, 2022 DOI:
https://doi.org/10.4143/crt.2022.232
Breast cancer
Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline
BRCA
1/2
Mutation
Ju Won Kim, Hyo Eun Kang, Jimi Choi, Seung Gyu Yun, Seung Pil Jung, Soo Yeon Bae, Ji Young You, Yoon-Ji Choi, Yeul Hong Kim, Kyong Hwa Park
Cancer Res Treat.
2023;55(1):155-166. Published online June 8, 2022 DOI:
https://doi.org/10.4143/crt.2021.1567
Web of Science 1
Crossref 1
Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with
BRCA
1
/
2
Mutation-Negative Breast Cancer
Ji Soo Park, Saeam Shin, Yoon Jung Lee, Seung-Tae Lee, Eun Ji Nam, Jung Woo Han, Sun Hwa Lee, Tae Il Kim, Hyung Seok Park
Cancer Res Treat.
2022;54(4):1099-1110. Published online November 17, 2021 DOI:
https://doi.org/10.4143/crt.2021.978
Web of Science 1
Crossref 2
General
Reclassification of Five
BRCA
1
/
2
Variants with Unknown Significance Using Complex Functional Study
Anikó Bozsik, János Papp, Vince Kornél Grolmusz, Attila Patócs, Edit Oláh, Henriett Butz
Cancer Res Treat.
2022;54(4):970-984. Published online February 8, 2022 DOI:
https://doi.org/10.4143/crt.2021.1078
Web of Science 2
Crossref 2
Breast cancer
Clinicopathological Characterization of Double Heterozygosity for
BRCA
1
and
BRCA
2
Variants in Korean Breast Cancer Patients
Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee
Cancer Res Treat.
2022;54(3):827-833. Published online October 13, 2021 DOI:
https://doi.org/10.4143/crt.2021.791
Web of Science 1
Crossref 1
General
Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
Boyoung Park, Dongwon Kim, Jiyoung Kim, Bom Yi Lee, Junghyun Yoon, Sung-Won Kim
Cancer Res Treat.
2022;54(2):375-382. Published online August 9, 2021 DOI:
https://doi.org/10.4143/crt.2021.449
Increased Radiosensitivity of Solid Tumors Harboring
ATM
and
BRCA
1/2
Mutations
Kyung Hwan Kim, Han Sang Kim, Seung-seob Kim, Hyo Sup Shim, Andrew Jihoon Yang, Jason Joon Bock Lee, Hong In Yoon, Joong Bae Ahn, Jee Suk Chang
Cancer Res Treat.
2022;54(1):54-64. Published online June 4, 2021 DOI:
https://doi.org/10.4143/crt.2020.1247
Web of Science 10
Crossref 11
Breast Cancer
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline
BRCA
1/2
Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial
Kyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, Tiziana Usari, Silvana Lanzalone, Seock-Ah Im, Sung-Bae Kim
Cancer Res Treat.
2021;53(4):1084-1095. Published online March 24, 2021 DOI:
https://doi.org/10.4143/crt.2020.1381
Web of Science 4
Crossref 6
Gynecologic cancer
Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with
BRCA
1
or
BRCA
2
Mutation
Go Woon Jeong, Wonkyo Shin, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim
Cancer Res Treat.
2021;53(1):207-211. Published online August 11, 2020 DOI:
https://doi.org/10.4143/crt.2020.364
Web of Science 7
Crossref 6
Germline and Somatic
BRCA
1/2
Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.
2020;52(4):1229-1241. Published online July 27, 2020 DOI:
https://doi.org/10.4143/crt.2020.557
Web of Science 10
Crossref 3
Clinicopathological Features of Patients with the
BRCA
1
c.5339T>C (p.Leu1780Pro) Variant
Hyung Seok Park, Jai Min Ryu, Ji Soo Park, Seock-Ah Im, So-Youn Jung, Eun-Kyu Kim, Woo-Chan Park, Jun Won Min, Jeeyeon Lee, Ji Young You, Jeong Eon Lee, Sung-Won Kim
Cancer Res Treat.
2020;52(3):680-688. Published online January 28, 2020 DOI:
https://doi.org/10.4143/crt.2019.351
Web of Science 7
Crossref 7
Clinical and Genetic Characteristics of
BRCA
1/2
Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
Cancer Res Treat.
2019;51(3):941-950. Published online October 8, 2018 DOI:
https://doi.org/10.4143/crt.2018.312
Web of Science 8
Crossref 8
Different Patterns of Risk Reducing Decisions in Affected or Unaffected
BRCA
Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Web of Science 10
Crossref 9
Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
BRCA
1
and
BRCA
2
Sang Mee Hwang, Ki Chan Lee, Min Seob Lee, Kyoung Un Park
Cancer Res Treat.
2018;50(1):255-264. Published online April 7, 2017 DOI:
https://doi.org/10.4143/crt.2017.062
Web of Science 3
Crossref 3
Identification of a Novel
BRCA
1
Pathogenic Mutation in Korean Patients Following Reclassification of
BRCA
1
and
BRCA
2
Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
Ji Soo Park, Eun Ji Nam, Hyung Seok Park, Jung Woo Han, Jung-Yun Lee, Jieun Kim, Tae Il Kim, Seung-Tae Lee
Cancer Res Treat.
2017;49(4):1012-1021. Published online January 17, 2017 DOI:
https://doi.org/10.4143/crt.2016.433
Web of Science 23
Crossref 26
Clinically Significant Unclassified Variants in
BRCA
1
and
BRCA
2
Genes among Korean Breast Cancer Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2017;49(3):627-634. Published online September 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.292
Web of Science 12
Crossref 10
Comparison of Clinical Outcomes of
BRCA
1/2
Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
Kyung Jin Eoh, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Jeongwoo Han, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Eun Ji Nam
Cancer Res Treat.
2017;49(2):408-415. Published online July 27, 2016 DOI:
https://doi.org/10.4143/crt.2016.135
Web of Science 27
Crossref 25
Analysis of
BRIP1
Variants among Korean Patients with
BRCA
1/2
Mutation-Negative High-Risk Breast Cancer
Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Gee Hue Jung, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Won Ho Gil, Seok Won Kim
Cancer Res Treat.
2016;48(3):955-961. Published online January 19, 2016 DOI:
https://doi.org/10.4143/crt.2015.191
Web of Science 7
Crossref 7
Novel Germline Mutation of
BRCA
1
Gene in a 56-Year-Old Woman with Breast Cancer, Ovarian Cancer, and Diffuse Large B-Cell Lymphoma
Hye Sook Kim, Soon Wook Lee, Yoon Ji Choi, Sang Won Shin, Yeul Hong Kim, Min Sun Cho, Soon Nam Lee, Kyong Hwa Park
Cancer Res Treat.
2015;47(3):534-538. Published online October 17, 2014 DOI:
https://doi.org/10.4143/crt.2013.151
Web of Science 6
Crossref 6
Flow Cytometric Analysis of
BRCA
1 Protein in Sporadic Breast Cancer
Seung Moo Lee, Kyung Soon Sons, Hee Dae Lee
J Korean Cancer Assoc.
1998;30(4):701-710.
Germline Mutation of
BRCA
2 Gene in Korean Breast / Ovarian Cancer Families
Yong Jin Won, Jae Hwan Oh, Ji Hyun Kim, Dong Young Noh, Kuk Jin Choe, Soon Beom Kang, Lee Su Kim, Man Su Ro, Nam Sun Paik, Dae Hyun Yang, Se Min Oh, Soon Nam Lee, Kyung Kook Kim, Jae Gahb Park
J Korean Cancer Assoc.
1998;30(2):242-252.
Germline Mutations of
BRCA
1 Gene in Korean Breast and/or Ovarian Cancer Families
Yong Jin Won, Jae Hwan Oh, Xiao Hong Huang, Dong Young Noh, Kuk Jin Choe, Soon Beom Kang, Lee Su Kim, Man Su Noh, Nam Sun Paik, Dae Hyun Yang, Se Min Oh, Soon Nam Lee, Jae Gahb Park
J Korean Cancer Assoc.
1997;29(5):713-723.
Germline Mutation of
BRCA
1 Gene in Korean Breast and Overian Cancer Patients
Jae Hwan Oh, Dong Young Noh, Kuk Jin Choe, Soon Beom Kang, Lee Su Kim, Man Su Ro, Nam Sun Paik, Dae Hyun Yang, Se Min Oh, Soon Nam Lee, Jae Gahb Park
J Korean Cancer Assoc.
1995;27(6):1061-1070.
1
Journal Impact Factor 4.6
> Browse Articles > Search
